Single Shot at Doctor's Office May Be Future of HIV Prevention | NBC 5 Dallas-Fort Worth
National & International News
The day’s top national and international news

Single Shot at Doctor's Office May Be Future of HIV Prevention

The National Institutes of Health announced last week that it was entering the first-ever global clinical trial of an injectable HIV-prevention drug

    processing...

    NEWSLETTERS

    Getty Images
    File - Syringe with hypodermic needle

    The Truvada pill is taken daily to prevent HIV and has been touted as a miracle drug responsible for lowering rates of the virus across the United States. But soon, the daily pill may be overshadowed by an even simpler method — a single flu shot-like injection at the doctor's office, once every two months, NBC News reported. 

    The National Institutes of Health announced last week that it was entering the first-ever global clinical trial of an injectable HIV-prevention drug called cabotegravir. The trial is taking place in eight countries across three world regions — the Americas, Africa and Asia — and researchers are enrolling 4,500 gay and bisexual men along with transgender women, pulling from groups with the highest rates of new infections.

    Five Viral Moments From Trump's Trip Abroad

    [NATL] Five Viral Moments From Trump's Trip Abroad

    President Donald Trump's first trip abroad since taking office has been filled with viral moments. Here are five that had people talking and tweeting.

    (Published Thursday, May 25, 2017)

    "The annual number of new HIV infections among young people, especially young men who have sex with men and transgender women who have sex with men, has been on the rise despite nearly flat HIV incidence among adults worldwide," said Raphael J. Landovitz, the protocol chair for the study.